Evidence map›Paper›PMID 33976605›Full record

ArticleEngineering in life sciences2021

Applicability of a single-use bioreactor compared to a glass bioreactor for the fermentation of filamentous fungi and evaluation of the reproducibility of growth in pellet form.

Winda Soerjawinata, Konstantin Schlegel, Natalie Fuchs, Anja Schüffler, Tanja Schirmeister, Roland Ulber, Percy Kampeis

Abstract read
In one paragraph

Article in Engineering in life sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Production of Protease Inhibitor WithEngineering in life sciences · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Winda SoerjawinataInstitute for Biotechnical Process Design Trier University of Applied Sciences, Environmental Campus Birkenfeld Hoppstädten-Weiersbach Germany.
Konstantin SchlegelInstitute for Biotechnical Process Design Trier University of Applied Sciences, Environmental Campus Birkenfeld Hoppstädten-Weiersbach Germany.
Natalie FuchsInstitute of Pharmaceutical and Biomedical Sciences Johannes Gutenberg University Mainz Mainz Germany.
Anja SchüfflerInstitut für Biotechnologie und Wirkstoff-Forschung gGmbH (IBWF) Mainz Germany.
Tanja SchirmeisterInstitute of Pharmaceutical and Biomedical Sciences Johannes Gutenberg University Mainz Mainz Germany.
Roland UlberInstitute of Bioprocess Engineering Technical University Kaiserslautern Kaiserslautern Germany.ORCID https://orcid.org/0000-0002-7674-0967
Percy KampeisInstitute for Biotechnical Process Design Trier University of Applied Sciences, Environmental Campus Birkenfeld Hoppstädten-Weiersbach Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The implementation of single-use technologies offers several major advantages, e.g. prevention of cross-contamination, especially when spore-forming microorganisms are present. This study investigated the application of a single-use bioreactor in batch fermentation of filamentous fungus

Indexed as

fermentationpelletsPenicillium spprotease inhibitorsingle‐use bioreactor

Identifiers

PMID33976605
PMCPMC8092982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.